Hematopoietic Cell Growth Factors

Subscribe to Selected New Research on Hematopoietic Cell Growth Factors

11 relevant articles (0 outcomes, 2 trials/studies) found for this Bio-Agent

Description: These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.

Also Known As:

Hematopoietic Cell Growth Factor; Hematopoietic Stem Cell Stimulators; Hematopoietic Stem Cell-Activating Factors; Hematopoietic-CGF; Hematopoietic CGF; Hematopoietins

Bio-Agent Context: Research Results

Experts

1.	Longmore, Gregory D: 1 article (01/2005)
2.	Anderson, David W: 1 article (01/2005)
3.	Jones, Kevin B: 1 article (01/2005)

Related Diseases

1.	HIV Infections (HIV Infection) 04/01/1991 - "Novel clinical approaches using hematopoietins alone or in combination with antimicrobial, antiviral, and antitumor drugs represent exciting developments in the treatment of HIV infection." 01/01/1990 - "Investigations of the hematopoietic, virologic, and immunologic effects of these agents alone and in combination with other hematopoietins, cytokines, and chemotherapeutic agents will ultimately define their clinical utility in patients with HIV infection." 08/01/1988 - "Studies of the use of GM-CSF alone and in combination with antiretroviral, antimicrobial, antineoplastic agents or other hematopoietins and cytokines will help define its ultimate clinical utility in patients with HIV infection." Order ALL the reference details at left...
2.	Neutropenia 01/01/1992 - "Studies of the effectiveness of hematopoietic cell growth factors for improving recovery from chemotherapy-induced neutropenia use the duration of neutropenia as the main end-point. " Order ALL the reference details at left...
3.	Infection 06/15/1992 - "The detection of this activity associated with MPSV infection stimulated us to characterize the hematopoietins responsible for this activity. " 01/01/2007 - "Interleukine-6 (IL-6) is an immune protein belonging to the family of the hematopoietins, liberated in response to infection, burns, trauma, and neoplastic diseases. " Order ALL the reference details at left...
4.	Eosinophilia-Myalgia Syndrome 11/01/1990 - "The recent recognition of the eosinophilia-myalgia syndrome (EMS) associated with the ingestion of L-tryptophan prompted an analysis of the peripheral blood eosinophil phenotypes and of the serum eosinophil hematopoietins in this disorder. " Order ALL the reference details at left...
5.	Wounds and Injuries (Trauma) 01/01/2007 - "Interleukine-6 (IL-6) is an immune protein belonging to the family of the hematopoietins, liberated in response to infection, burns, trauma, and neoplastic diseases. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cytokines
2.	Antineoplastic Agents (Antineoplastics)
3.	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
4.	Tryptophan (L-Tryptophan)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Bone Marrow Transplantation (Transplantation, Bone Marrow)

Best Treatments:
Research Summary Report
on HIV Infections

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 555 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>